Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: Relations with lipid transfer proteins and LCAT activities

Journal of Lipid Research

Volumn 39, Issue 7, 1998, Pages 1493-1502

  Mero, N ^a   Van Tol, A ^b   Scheek, L M ^b   Van Gent, T ^b   Labeur, C ^c   Rosseneu, M ^c   Taskinen, M R ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Alimentary lipemia; Apolipoprotein A I particles; Apolipoprotein C; Atherogenesis; Cholesteryl ester transfer protein; Esterification rate; Phospholipid transfer protein; Triglyceride rich lipoproteins

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID TRANSFER PROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID TRANSFER PROTEIN;

ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; LIPID COMPOSITION; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; BLOOD GLUCOSE; C-PEPTIDE; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL ESTERS; CHOLESTEROL, HDL; DIETARY FATS; GLYCOPROTEINS; HUMANS; INSULIN; LIPOPROTEINS, VLDL; MALE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; POSTPRANDIAL PERIOD; REFERENCE VALUES; SMOKING; TIME FACTORS;

EID: 0031851537     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Hammond, E., and D. Horn. 1958. Smoking and death rates - report on 44 months of follow-up of 187,783 men. Death rates by cause. J. Am. Med. Assoc. 166: 1294-1308.
2. Kannel, W. B. 1981. Update on the role of cigarette smoking in coronary artery disease. Am. Heart J. 101: 319-328.
3. Gottlieb, S., J. Fallavollita, M. McDermont, M. Brown, S. Eberly, and A. J. Moss. 1994. Cigarette smoking and the age at onset of a first non-fatal myocardial infarction. Coron. Artery Dis. 5: 687-694.
4. Craig, W. Y., G. E. Palomaki, and J. E Haddow. 1989. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br. Med. J. 298: 784-788.
5. Freeman, D. J., B. A. Griffin, E. Murray, G. M. Lindsay, D. Gaffney, C. J. Packard, and J. Shepherd. 1993. Smoking increases plasma lipoproteins in man: effects of low density lipoprotein cholesterol levels and high density lipoprotein subtraction distribution. Eur. J. Clin. Invest. 23: 630-640.
6. Zilversmit, D. B. 1979. Atherogenesis: a postprandial phenomenon. Circulation. 60: 473-485.
7. Elkeles, R. S., S. R. Khan, V. Chowdhury, and B. Swallow. 1983. Effects of smoking on oral fat tolerance and high density lipoprotein cholesterol. Clin. Sci. 65: 669-672.
8. Axelsen, M., B. Eliasson, E. Joheim, R. A. Lenner, M-R. Taskinen, and U. Smith. 1995. Lipid intolerance in smokers. J. Intern. Med. 237: 449-455.
9. Mero, N., M. Syvänne, B. Eliasson, U. Smith, and M-R. Taskinen. 1997. Postprandial elevation of apoB-48-containing triglyceride-rich particles and retinyl esters in normolipemic men who smoke. Arterioscler. Thromb. Vasc. Biol. 17: 2096-2102.
10. Castro, G. R., and C. J. Fielding. 1985. Effects of postprandial lipemia on plasma cholesterol metabolism. J. Clin. Invest. 75: 874-882.
11. Tall, A., D. Sammett, and E. Granot. 1986. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. J. Clin. Invest. 77: 1163-1172.
12. Applebaum-Bowden, D. 1995. Lipases and lecithin:cholesterol acyltransferase in the control of lipoprotein metabolism. Curr. Opin. Lipidol. 6: 130-135.
13. Dullaart, R. P. F., K. Hoohenberg, B. D. Dikkeschei, and A. van Tol. 1994. Higher plasma lipid transfer protein activities and unfavourable lipoprotein changes in cigarette-smoking men. Arterioscler. Thromb. 14: 1581-1585.
14. De Parscau, L., and C. J. Fielding. 1986. Abnormal plasma cholesterol metabolism in cigarette smokers. Metabolism. 35: 1070-1073.
15. Moriguchi, E. H., Y. Fusegawa, H. Tamachi, and Y. Goto. 1990. Effects of smoking on HDL subfractions in myocardial infarction patients: effects of lecithin-cholesterol acyltransferase and hepatic lipase. Clin. Chim. Acta. 195: 139-144.
16. Cohn, J. S., J. R. McNamara, S. D. Cohn, J. M. Ordovas, and E. J. Schaefer. 1988. Postprandial plasma lipoprotein changes in human subjects of different ages. J. Lipid Res. 29: 469-479.
17. Karpe, F., and A. Hamsten. 1994. Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J. Lipid Res. 35: 1311-1317.
18. Morton, R. E., and D. B. Zilversmit. 1981. A plasma inhibitor of triglyceride and cholesteryl ester transfer activities. J. Biol. Chem. 256: 11992-11995.
19. Redgrave, T., C. C. K. Roberts, and C. E. West. 1975. Separation of plasma lipoproteins by density gradient ultracentrifugation. Anal. Biochem. 65: 42-49.
20. Van Tol, A., J. J. M. Ligtenberg, S. C. Riemens, T. W. van Haeften, W. D. Reitsma, and R. P. F. Dullaart. 1997. Lowering of plasma phospholipid transfer protein activity by acute hyperglycemia-induced hyperinsulinemia in healthy men. Scand. J. Clin. Lab. Invest. 57: 147-158.
21. Hannuksela, M., Y. L. Marcel, Y. A. Kesäniemi, and M. J. Savolainen. 1992. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J. Lipid Res. 33: 737-744.
22. 14C] phosphatidylcholine between liposomes and human plasma high density lipoprotein. Partial purification of a transfer-stimulating plasma factor using a rapid transfer assay. Biochim. Biophys. Acta. 712: 444-452.
23. Speijer, H., J. E. Groener, E. van Ramhorst, and A. van Tol. 1991. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis. 90: 159-168.
24. Glomset, J. A., and J. L. Wright. 1964. Some properties of a cholesterol esterifying enzyme in human plasma. Biochim. Biophys. Acta. 89: 266-276.
25. Streyrer, E., and G. M. Kostner. 1988. Activation of lecithin:cholesterol acyltransferase by apolipoprotein D, A-I or C-I. Biochim. Biophys. Acta. 958: 484-491.
26. Channon, K. M., R. J. Clegg, D. Bhatnagar, M. Ishola, S. Arrol, and P. N. Durrington. 1990. Investigation of lipid transfer in human serum leading to the development of an isotopic method for determination of endogenous cholesterol esterification and transfer. Atherosclerosis. 80: 217-226.
27. Lagrost, L., A. Athias, B. Herbeth, V. Guyard-Dangremont, Y. Arthur, F. Paille, P. Gambert, and C. Lallemant. 1996. Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. J. Biol. Chem. 271: 19058-19065.
28. Bury, J., R. Vercaemst, M. Rosseneu, and F. Belpaire. 1986. Quantitation of human apolipoprotein E by enzyme-linked immunosorbent assay. Clin. Chem. 32: 265-270.
29. Parra, H. J., H. Mezdour, N. Ghalim, J. M. Bard, and J. C. Fruchart. 1990. Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates. Clin. Chem. 36: 1431-1435.
30. Havekes, L. M., P. de Knijff, U. Beisiegel, J. Havinga, M. Smith, and E. Klasen. 1987. A rapid micromethod for apolipoprotein E phenotyping directly in serum. J. Lipid. Res. 28: 455-463.
31. Curwall, M., E. Kazemi-Vala, and C. R. Enzell. 1982. Simultaneous determination of nicotine and cotinine in plasma using capillary column gas chromatography with nitrogen-sensitive detection. J. Chromatogr. 232: 283-293.
32. Huttunen, J. K., C. Ehnholm, P. K. J. Kinnunen, and E. A. Nikkilä. 1975. An immunochemical method for selective measurement of two triglyceride lipases in human postheparin plasma. Clin. Chim. Acta. 63: 335-347.
33. Matthews, J., D. Altman, M. Campbell, and P. Royston. 1990. Analysis of serial measurements in medical research. Br. Med. J. 300: 230-235.
34. Gordon, D. J., J. L. Probstfield, R. J. Garrison, J. D. Neaton, W. P. Castelli, J. D. Knoke, D. R. J. Jacobs, S. Bangdiwala, and H. A. Tyroler. 1989. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation. 79: 8-15.
35. O'Brien, T., T. T. Nguyen, B. J. Hallaway, D. Hodge, K. Bailey, D. Holmes, and B. A. Kottke. 1995. The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 15: 228-231.
36. Karpe, F., J. M. Bard, G. Steiner, L. A. Carlson, J. C. Fruchart, and A. Hamsten. 1993. HDLs and alimentary lipemia. Studies in men with previous myocardial infarction at a young age. Arterioscler. Thromb. 13: 11-22.
37. Patsch, J. R., J. B. Karlin, L. W. Scott, L. C. Smith, and A. M. Gotto. 1983. Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc. Natl. Acad. Sci. USA. 80: 1449-1453.
38. Bruce, C., and A. R. Tall. 1995. Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis. Curr. Opin. Lipidol. 6: 306-311.
39. Föger, B., A. Ritsch, A. Doblinger, H. Wessels, and J. R. Patsch. 1996. Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia. Arterioscler. Thromb. Vasc. Biol. 16: 1430-1436.
40. Van Tol, A., J. E. Groener, L. M. Scheek, T. Van Gent, J. Veenstra, H. Van de Pol, H. F. Hendriks, and G. Schaafsma. 1995. Induction of net mass lipid transfer in plasma by wine consumption with dinner. Eur. J. Clin. Invest. 25: 390-395.
41. Tall, A. R., S. Krumholz, T. Olivecrona, and R. J. Deckelbaum. 1985. Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoprotein during lipolysis. J. Lipid Res. 26: 842-851.
42. Jauhiainen, M., J. Metso, R. Pahlman, S. Blomquist, A. van Tol, and C. Ehnholm. 1993. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J. Biol. Chem. 268: 4032-4036.
43. Tu, A., H. I. Nishida, and T. Nishida. 1993. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J. Biol. Chem. 268: 23098-23105.
44. Lusa, S., M. Jauhiainen, J. Metso, P. Somerharju, and C. Ehnholm. 1996. The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: Evidence for particle fusion. Biochem. J. 313: 275-282.
45. Von Eckardstein, A., M. Jauhiainen, Y. Huang, J. Metso, C. Langer, P. Pussinen, S. Wu, C. Ehnholm, and G. Assmann. 1996. Phospholipid transfer protein-mediated conversion of high density lipoproteins generates preβ-HDL. Biochim. Biophys. Acta. 1301: 255-262.
46. Alberts, J. J., G. Wolfbauer, M. C. Cheung, M. C. Day, A. F. T. Ching, S. Lok, and A-Y. Tu. 1995. Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plasma PLTP on HDL subspecies. Biochim. Biophys. Acta. 1258: 27-34.
47. McCall, M. R., J. J. M. van den Berg, F. A. Kuypers, D. L. Tribble, R. M. Krauss, L. J. Knoff, and T. M. Forte. 1994. Modification of LCAT activity and HDL structure. New links between cigarette smoke and coronary heart disease risk. Arterioscler. Thromb. 14: 248-253.
48. Fielding, C. J., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228.
49. Beisiegel, U., W. Weber, G. Ihrke, J. Herz, and K. K. Stanley. 1989. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature. 341: 162-164.
50. Smit, M., P. Knijff, M. Rosseneu, J. Bury, E. Klasen, R. Frants, and L. Havekes. 1988. Apolipoprotein E polymorphism in the Netherlands and its effect on plasma lipid and apolipoprotein levels. Hum. Genet. 80: 287-292.
51. Cohn, J. S., J. R. McNamara, S. D. Cohn, J. M. Ordovas, and E. J. Schaefer. 1988. Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal. J. Lipid Res. 29: 925-936.
52. Syvänne, M., M. Rosseneu, C. Labeur, H. Hilden, and M. R. Taskinen. 1994. Enrichment with apolipoprotein E characterizes post-prandial TG-rich lipoproteins in patients with non-insulin-dependent diabetes mellitus and coronary artery disease: a preliminary report. Atherosclerosis. 105: 25-34.
53. Mero, N., M. Syvänne, M. Rosseneau, C. Labeur, H. Hilden, and M-R. Taskinen. 1998. Comparison of three fatty meals in healthy normolipidemic men: high postprandial retinyl ester response to soybean oil. Eur. J. Clin. Invest. In press.
54. Ji, Z. S., J. W. Brecht, R. D. Miranda, M. M. Hussain, T. L. Innerarity, and R. W. Mahley. 1993. Role of heparan sulphate proteoglycans in the binding and the uptake of apolipoprotein enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 268: 10160-10167.
55. Bradley, W. A., and S. H. Gianturco. 1986. ApoE is necessary and sufficient for binding of large very low density lipoproteins to the LDL receptor; apoB is unnecessary. J. Lipid Res. 27: 40-48.
56. Connelly, P. W., G. F. Maguire, C. Vezina, R. A. Hegele, and A. Kuksis. 1994. Kinetics of lipolysis of very low density lipoprotein by lipoprotein lipase. J. Biol. Chem. 269: 20554-20560.
57. Cohn, J. S., M. Tremblay, M. Amiont, D. Bouthiller, M. Roy, J. J. Genest, and J. Davignon. 1996. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects. Arterioscler. Thromb. Vasc. Biol. 16: 149-159.
58. Koo, C., T. L. Innerarity, and R. W. Mahley. 1985. Obligatory role of cholesterol and apolipoprotein E in the formation of large cholesterol-enriched and receptor-active high density lipoproteins. J. Biol. Chem. 260: 11934-11943.
59. Funke, H., J. Boyles, K. H. Weisgraber, E. H. Ludwig, D. Y. Hui, and R. W. Mahley. 1984. Uptake of apolipoprotein E-containing high density lipoproteins by hepatic parenchymal cells. Arteriosclerosis. 4: 452-461.
60. Benowitz, N. 1988. Pharmacologic aspects of cigarette smoking and nicotine addiction. N. Engl. J. Med. 319: 1318-1330.
61. Skottova, N., R. Savonen, A. Lookene, M. Hultin, and G. Olivecrona. 1995. Lipoprotein lipase enhances removal of chylomicrons and chylomicron remnants by the perfused rat liver. J. Lipid Res. 36: 1334-1344.